Intelligent Bio Financials
| INBS Stock | USD 9.87 3.94 28.53% |
Intelligent | Build AI portfolio with Intelligent Stock |
Understanding current and past Intelligent Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Intelligent Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Intelligent Bio's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Intelligent Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Intelligent Bio Solutions. Check Intelligent Bio's Beneish M Score to see the likelihood of Intelligent Bio's management manipulating its earnings.
Intelligent Bio Stock Summary
Intelligent Bio competes with Mainz Biomed, PAVmed, Matinas BioPharma, Heart Test, and STRATA Skin. GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Intelligent Bio operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US36151G6008 |
| Business Address | 135 West, 41st |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | ibs.inc |
| Phone | 646 828 8258 |
| Currency | USD - US Dollar |
Intelligent Bio Key Financial Ratios
Intelligent Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intelligent Bio's current stock value. Our valuation model uses many indicators to compare Intelligent Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intelligent Bio competition to find correlations between indicators driving Intelligent Bio's intrinsic value. More Info.Intelligent Bio Solutions is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Intelligent Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Intelligent Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Intelligent has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Intelligent Bio's financials are consistent with your investment objective using the following steps:- Review Intelligent Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Intelligent Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Intelligent Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Intelligent Bio's stock is overvalued or undervalued.
Intelligent Bio January 21, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Intelligent Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intelligent Bio Solutions. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intelligent Bio Solutions based on widely used predictive technical indicators. In general, we focus on analyzing Intelligent Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intelligent Bio's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.72 | |||
| Information Ratio | 0.0571 | |||
| Maximum Drawdown | 149.65 | |||
| Value At Risk | (14.84) | |||
| Potential Upside | 20.86 |
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.